{
  "abstract": "Screening with a PSA (prostate specific antigen) blood test reduces prostate cancer deaths by two for every 1000 men screened, though the risk of overdiagnosis remains high, an updated Cochrane review says.1",
  "authors": [
    {
      "affiliations": [
        "Kent"
      ],
      "name": "Jacqui Wise"
    }
  ],
  "title": "Prostate cancer: Screening “modestly” reduces deaths, Cochrane review concludes",
  "uid": "61b184ac-9ea0-5c20-9e3e-3798de2a7bb4"
}
